LON:IBT International Biotechnology Trust (IBT) Share Forecast, Price & News GBX 656.90 -7.10 (-1.07%) (As of 03:28 PM ET) Add Compare Share Share Today's Range 651.66▼ 658.9850-Day Range 640▼ 68852-Week Range 588▼ 744Volume36,343 shsAverage Volume51,580 shsMarket Capitalization£266.70 millionP/E RatioN/ADividend Yield4.26%Price TargetN/A ProfileProfileChartCompetitorsDividendInsider TradesHeadlinesProfileChartCompetitorsDividendInsider TradesHeadlines About International Biotechnology Trust (LON:IBT) StockInternational Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.Read More Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesMay 27, 2023 | finance.yahoo.comIBT.L - International Biotechnology Trust plcApril 25, 2023 | msn.comUS consumer confidence falls to 9-month low in AprilMay 30, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.February 14, 2023 | lse.co.ukSV Health notifies International Biotechnology of termination in 2024February 13, 2023 | lse.co.ukSMALL-CAP WINNERS & LOSERS: Non-Standard drops on insolvency warningDecember 8, 2022 | uk.finance.yahoo.comHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&ANovember 10, 2022 | msn.comWe’re confident healthcare stocks will recover, so investors should buy these fundsSeptember 6, 2022 | reuters.comBharat Biotech's COVID-19 nasal vaccine approved for restricted use in IndiaMay 30, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.July 3, 2022 | thetimes.co.ukOur expanding waistbands may stop me from having to tighten my beltJune 30, 2022 | uk.finance.yahoo.comHardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the riseJanuary 3, 2022 | thetimes.co.ukIan Cowie: Five investment reasons to be cheerfulDecember 4, 2021 | finanznachrichten.deHardman & Co Research: International Biotechnology Trust (IBT) - Access to fast-growing biotechnology companiesDecember 3, 2021 | uk.finance.yahoo.comHardman & Co Research : International Biotechnology Trust (IBT) - Access to fast-growing biotechnology companiesNovember 4, 2021 | lse.co.ukInt.biotech. Share ChatOctober 27, 2021 | uk.finance.yahoo.comInternational Biotechnology Trust plc (IBT.L)September 2, 2021 | wsj.comTrade-Van Information Services Co. Ltd.August 6, 2021 | prnewswire.comTeamsters Local 533 On Strike Against RTC Washoe Bus Contractor Keolis TransitMay 6, 2021 | news.yahoo.comIs San Francisco on the verge of a herd immunity breakthrough? Experts are optimisticApril 14, 2021 | investing.comInternational Biotechnology Trust plc (IBT)March 15, 2021 | marketwatch.comThe new stimulus bill will help shore up some shaky pension plansFebruary 5, 2021 | markets.businessinsider.comJohn Vander Lans Joins BNBuilders as Sr. Project Executive in the Los Angeles, Orange County, and Inland Empire MarketsFebruary 3, 2021 | foxnews.comHow the ‘Python Cowboy’ plans to solve Florida’s snake problemFebruary 3, 2021 | nasdaq.comIFR SNAPSHOT - IG primary hosts five offerings, HY sees four deals; Alibaba starts marketingFebruary 3, 2021 | theguardian.comCoronavirus live news: Oxford/AstraZeneca aiming to update vaccine by autumn; Denmark to launch vaccine passFebruary 1, 2021 | reuters.comBayer and Rentschler to help produce CureVac's COVID-19 shotFebruary 1, 2021 | apnews.comAiCuris Changes its Legal Form: AiCuris Anti-infective Cures GmbH becomes AiCuris AGSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorFinance Current SymbolLON:IBT CUSIPN/A CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.55) Trailing P/E RatioN/A Forward P/E Ratio702.37 P/E GrowthN/ANet Income£-22,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-7.38% Return on Assets-3.20% Debt Debt-to-Equity Ratio14.03 Current Ratio0.32 Quick Ratio0.32 Sales & Book Value Annual Sales£-13,580,000.00 Price / Sales-19.81 Cash FlowGBX 4.26 per share Price / Cash Flow155.74 Book ValueGBX 697 per share Price / Book0.95Miscellaneous Outstanding Shares40,600,000Free FloatN/AMarket Cap£269.08 million OptionableNot Optionable Beta0.24 Key ExecutivesMs. Lucy Costa DuarteHead of Investor RelationsMs. Catherine Elizabeth Bingham M.B.A. (Age 57)Managing Partner Ms. Ailsa CraigInvestment Mang.Mr. Marek Poszepczynski M Sci EngInvestment Mang.Claire JacksonCompany Sec.Dr. Carl Harald JansonLead Investment Mang.More ExecutivesKey CompetitorsTatton Asset ManagementLON:TAMabrdn New Dawn Investment TrustLON:ABDRiverstone EnergyLON:RSEInvesco Bond Income PlusLON:BIPSReal Estate Credit InvestmentsLON:RECIView All Competitors IBT Stock - Frequently Asked Questions How have IBT shares performed in 2023? International Biotechnology Trust's stock was trading at GBX 706 at the start of the year. Since then, IBT shares have decreased by 6.1% and is now trading at GBX 662.75. View the best growth stocks for 2023 here. How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust? International Biotechnology Trust announced a dividend on Tuesday, December 6th. Shareholders of record on Thursday, December 29th will be given a dividend of GBX 14 per share on Friday, January 27th. This represents a dividend yield of 2.01%. The ex-dividend date is Thursday, December 29th. The official announcement can be accessed at this link. Read our dividend analysis for IBT. Is International Biotechnology Trust a good dividend stock? International Biotechnology Trust (LON:IBT) pays an annual dividend of GBX 28 per share and currently has a dividend yield of 4.20%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for IBT. What other stocks do shareholders of International Biotechnology Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology Trust investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX). What is International Biotechnology Trust's stock symbol? International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT." How do I buy shares of International Biotechnology Trust? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is International Biotechnology Trust's stock price today? One share of IBT stock can currently be purchased for approximately GBX 662.75. How much money does International Biotechnology Trust make? International Biotechnology Trust (LON:IBT) has a market capitalization of £269.08 million and generates £-13,580,000.00 in revenue each year. The company earns £-22,470,000.00 in net income (profit) each year or GBX (0.55) on an earnings per share basis. How can I contact International Biotechnology Trust? International Biotechnology Trust's mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The official website for the company is www.ibtplc.com. The company can be reached via phone at 44 20 7421 7070. This page (LON:IBT) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Trust plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.